Rapid, comprehensive analysis of the dystrophin transcript by a custom micro-fluidic exome array

Human Mutation

Volumn 33, Issue 3, 2012, Pages 572-581

  Bovolenta, Matteo ^a   Scotton, Chiara ^a   Falzarano, Maria Sofia ^a   Gualandi, Francesca ^a   Ferlini, Alessandra ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Diagnostic biomarker; DMD mutations; Fluidic cards; RNA analysis

Indexed keywords

BIOLOGICAL MARKER; DYSTROPHIN; MESSENGER RNA;

ARTICLE; EXOME; GENE DELETION; HUMAN; HUMAN CELL; HUMAN TISSUE; MEDICAL TECHNOLOGY; MICROARRAY ANALYSIS; MICROFLUIDICS; MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROCESSING; SENSITIVITY ANALYSIS; SKIN; VALIDATION STUDY;

DYSTROPHIN; EXOME; HUMANS; MALE; MUTATION; RNA;

EID: 84857051254     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.22017     Document Type: Article

References (28)

1. Abbs S, Tuffery-Giraud S, Bakker E, Ferlini A, Sejersen T, Mueller CR. 2010 Best practice guidelines on molecular diagnostics in Duchenne/Becker muscular dystrophies. Neuromuscul Disord 20:422-427.
2. Bennett RR, den Dunnen J, O'Brien KF, Darras BT, Kunkel LM. 2001. Identification of mutations in the dystrophin gene via automated DHPLC screening and direct sequencing. BMC Genet 2:17.
3. Bonnal RJ, Severgnini M, Castaldi A, Bordoni R, Iacono M, Trimarco A, Torella A, Piluso G, Aurino S, Condorelli G, De Bellis G, Nigro V. 2010. Reliable resequencing of the human dystrophin locus by universal long polymerase chain reaction and massive pyrosequencing. Anal Biochem 406:176-184.
4. Bovolenta M, Neri M, Fini S, Fabris M, Trabanelli C, Venturoli A, Martoni E, Bassi E, Spitali P, Brioschi S, Falzarano MS, Rimessi P, Ciccone R, Ashton E, McCauley J, Yau S, Abbs S, Muntoni F, Merlini L, Gualandi F, Ferlini A. 2008. A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies. BMC Genomics 9:572.
5. Bovolenta M, Rimessi P, Dolcini B, Ravani A, Ferlini A, Gualandi F. 2010. Prenatal diagnosis of Duchenne muscular dystrophy by comparative genomic hybridization. Clin Genet 77:503-506.
6. Chaouch S, Mouly V, Goyenvalle A, Vulin A, Mamchaoui K, Negroni E, Di Santo J, Butler-Browne G, Torrente Y, Garcia L, Furling D. 2009. Immortalized skin fibroblasts expressing conditional MyoD as a renewable and reliable source of converted human muscle cells to assess therapeutic strategies for muscular dystrophies: validation of an exon-skipping approach to restore dystrophin in Duchenne muscular dystrophy cells. Hum Gene Ther 20:784-790.
7. Deburgrave N, Daoud F, Llense S, Barbot JC, Récan D, Peccate C, Burghes AH, Béroud C, Garcia L, Kaplan JC, Chelly J, Leturcq F. 2007. Protein and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene. Hum Mutat 28:183-195.
8. del Gaudio D, Yang Y, Boggs BA, Schmitt ES, Lee JA, Sahoo T, Pham HT, Wiszniewska J, Chinault AC, Beaudet AL, Eng CM. 2008. Molecular diagnosis of Duchenne/Becker muscular dystrophy: enhanced detection of dystrophin gene rearrangements by oligonucleotide array-comparative genomic hybridization. Hum Mutat 29:1100-1107.
9. Ferlini A, Sabatelli P, Fabris M, Bassi E, Falzarano S, Vattemi G, Perrone D, Gualandi F, Maraldi NM, Merlini L, Sparnacci K, Laus M, Caputo A, Bonaldo P, Braghetta P, Rimessi P. 2010. Dystrophin restoration in skeletal, heart and skin arrector pili smooth muscle of mdx mice by ZM2 NP-AON complexes. Gene Ther 17:432-438. Epub 2009 Nov 12.
10. Flanigan KM, Dunn DM, von Niederhausern A, Soltanzadeh P, Gappmaier E, Howard MT, Sampson JB, Mendell JR, Wall C, King WM, Pestronk A, Florence JM, Connolly AM, Mathews KD, Stephan CM, Laubenthal KS, Wong BL, Morehart PJ, Meyer A, Finkel RS, Bonnemann CG, Medne L, Day JW, Dalton JC, Margolis MK, Hinton VJ; United Dystrophinopathy Project Consortium, Weiss RB. 2009. Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort. Hum Mutat 30:1657-1666.
11. Flanigan KM, Dunn DM, von Niederhausern A, Soltanzadeh P, Howard MT, Sampson JB, Swoboda KJ, Bromberg MB, Mendell JR, Taylor L, Anderson CB, Pestronk A, Florence J, Connolly AM, Mathews KD, Wong B, Finkel RS, Bonnemann CG, Day JW, McDonald C, Weiss RB; the United Dystrophinopathy Project Consortium. 2011. Nonsense mutation-associated Becker muscular dystrophy: interplay between exon definition and splicing regulatory elements within the DMD gene. Hum Mutat. 32(3):299-308. (Epub ahead of print).
12. Flanigan KM, von Niederhausern A, Dunn DM, Alder J, Mendell JR, Weiss RB. 2003. Rapid direct sequence analysis of the dystrophin gene. Am J Hum Genet 72:931-939.
13. Fletcher S, Adams AM, Johnsen RD, Greer K, Moulton HM, Wilton SD. 2010. Dystrophin isoform induction in vivo by antisense-mediated alternative splicing. Mol Ther 18:1218-1223.
14. Goemans NM, Tulinius M, van den Akker JT, Burm BE, Ekhart PF, Heuvelmans N, Holling T, Janson AA, Platenburg GJ, Sipkens JA, Sitsen JM, Aartsma-Rus A, van Ommen GJ, Buyse G, Darin N, Verschuuren JJ, Campion GV, de Kimpe SJ, van Deutekom JC. 2011. Systemic administration of PRO051 in Duchenne's muscular dystrophy. N Engl J Med 364:1513-1522.
15. Gualandi F, Neri M, Bovolenta M, Martoni E, Rimessi P, Fini S, Spitali P, Fabris M, Pane M, Angelini C, Mora M, Morandi L, Mongini T, Bertini E, Ricci E, Vattemi G, Mercuri E, Merlini L, Ferlini A. 2009. Transcriptional behaviour of DMD gene duplications in DMD/BMD males. Hum Mutat 30:E310-E319.
16. Hamed SA, Hoffman EP. 2006. Automated sequence screening of the entire dystrophin cDNA in Duchenne dystrophy: point mutation detection. Am J Med Genet B Neuropsychiatr Genet 141B:44-50.
17. Hegde MR, Chin EL, Mulle JG, Okou DT, Warren ST, Zwick ME. 2008. Microarray-based mutation detection in the dystrophin gene. Hum Mutat 29:1091-1099.
18. Janssen B, Hartmann C, Scholz V, Jauch A, Zschocke J. 2005. MLPA analysis for the detection of deletions, duplications and complex rearrangements in the dystrophin gene: potential and pitfalls. Neurogenetics 6:29-35.
19. Kesari A, Pirra LN, Bremadesam L, McIntyre O, Gordon E, Dubrovsky AL, Viswanathan V, Hoffman EP. 2008. Integrated DNA, cDNA, and protein studies in Becker muscular dystrophy show high exception to the reading frame rule. Hum Mutat 29:728-737.
20. Kinali M, Arechavala-Gomeza V, Feng L, Cirak S, Hunt D, Adkin C, Guglieri M, Ashton E, Abbs S, Nihoyannopoulos P, Garralda ME, Rutherford M, McCulley C, Popplewell L, Graham IR, Dickson G, Wood MJ, Wells DJ, Wilton SD, Kole R, Straub V, Bushby K, Sewry C, Morgan JE, Muntoni F. 2009. Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. Lancet Neurol 8:918-928. Erratum in: Lancet Neurol. 2009 8:1083.
21. Lalic T, Vossen RH, Coffa J, Schouten JP, Guc-Scekic M, Radivojevic D, Djurisic M, Breuning MH, White SJ, den Dunnen JT. 2005 Nov; Deletion and duplication screening in the DMD gene using MLPA. Eur J Hum Genet 13:1231-1234.
22. Magri F, Del Bo R, D'Angelo MG, Govoni A, Ghezzi S, Gandossini S, Sciacco M, Ciscato P, Bordoni A, Tedeschi S, Fortunato F, Lucchini V, Cereda M, Corti S, Moggio M, Bresolin N, Comi GP. 2011. Clinical and molecular characterization of a cohort of patients with novel nucleotide alterations of the Dystrophin gene detected by direct sequencing. BMC Med Genet 11:12-37.
23. Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM. 1988. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 2:90-95.
24. Muntoni F, Torelli S, Ferlini A. 2003. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2:731-740.
25. Pichavant C, Aartsma-Rus A, Clemens PR, Davies KE, Dickson G, Takeda S, Wilton SD, Wolff JA, Wooddell CI, Xiao X, Tremblay JP. 2011. Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. Mol Ther 19:830-840.
26. Spitali P, Rimessi P, Fabris M, Perrone D, Falzarano S, Bovolenta M, Trabanelli C, Mari L, Bassi E, Tuffery S, Gualandi F, Maraldi NM, Sabatelli-Giraud P, Medici A, Merlini L, Ferlini A. 2009. Exon skipping-mediated dystrophin reading frame restoration for small mutations. Hum Mutat 30:1527-1534.
27. Tennyson CN, Shi Q, Worton RG. 1996. Stability of the human dystrophin transcript in muscle. Nucleic Acids Res 24:3059-3064.
28. Tuffery-Giraud S, Béroud C, Leturcq F, Yaou RB, Hamroun D, Michel-Calemard L, Moizard MP, Bernard R, Cossée M, Boisseau P, Blayau M, Creveaux I, Guiochon-Mantel A, de Martinville B, Philippe C, Monnier N, Bieth E, Khau Van Kien P, Desmet FO, Humbertclaude V, Kaplan JC, Chelly J, Claustres M. 2009. Genotype-phenotype analysis in 2, 405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase. Hum Mutat 30:934-945.